BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12203364)

  • 1. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
    Lin SY; Liang YC; Ho YS; Tsai SH; Pan S; Lee WS
    Mol Carcinog; 2002 Sep; 35(1):21-8. PubMed ID: 12203364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
    Sugibayashi R; Shimizu T; Suzuki T; Yamamoto N; Hamada H; Takeda K
    Oncogene; 2001 Mar; 20(10):1220-8. PubMed ID: 11313866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
    Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
    Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite.
    Kim JY; Choi JA; Kim TH; Yoo YD; Kim JI; Lee YJ; Yoo SY; Cho CK; Lee YS; Lee SJ
    J Cell Physiol; 2002 Jan; 190(1):29-37. PubMed ID: 11807808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.
    Burdon D; Patel R; Challiss RA; Blank JL
    Biochem J; 2002 Oct; 367(Pt 2):549-59. PubMed ID: 12126481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest.
    Detjen KM; Brembeck FH; Welzel M; Kaiser A; Haller H; Wiedenmann B; Rosewicz S
    J Cell Sci; 2000 Sep; 113 ( Pt 17)():3025-35. PubMed ID: 10934041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin V inhibits the 12-O-tetradecanoylphorbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells.
    Sato H; Ogata H; De Luca LM
    Oncogene; 2000 Jun; 19(25):2904-12. PubMed ID: 10871841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW; Nambirajan S; Moffat JG
    Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
    Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.
    Besson A; Yong VW
    Mol Cell Biol; 2000 Jul; 20(13):4580-90. PubMed ID: 10848585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing and extent of activation of diacylglycerol-responsive protein kinase-cs determines their ability to inhibit or promote platelet-derived growth factor-dependent DNA synthesis.
    Balciunaite E; Kazlauskas A
    Exp Cell Res; 2002 Dec; 281(2):167-74. PubMed ID: 12460646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
    Salabat MR; Ding XZ; Flesche JB; Ujiki MB; Robin TP; Talamonti MS; Bell RH; Adrian TE
    Pancreas; 2006 Aug; 33(2):148-55. PubMed ID: 16868480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.